1h Free Analyst Time
Global Tobacco Alternative Gums Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The tobacco alternative gums market is poised to grow by $ 660.60 mn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report on the tobacco alternative gums market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the demand for nicotine gum in smoking cessation therapy and increasing awareness about the harmful effects of cigarette smoking. In addition, the demand for nicotine gum in smoking cessation therapy is anticipated to boost the growth of the market as well.
The tobacco alternative gums market analysis includes type segment and geographical landscapes.
The tobacco alternative gums market is segmented as below:
By Type
- 2-mg nicotine gum
- 4-mg nicotine gum
By Geographical landscapes
- North America
- Europe
- APAC
- MEA
- South America
This study identifies rising prices of cigarettes as one of the prime reasons driving the tobacco alternative gums market growth during the next few years.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The tobacco alternative gums market covers the following areas:
- Tobacco alternative gums market sizing
- Tobacco alternative gums market forecast
- Tobacco alternative gums market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tobacco alternative gums market vendors that include Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, ITC Ltd., Johnson & Johnson, Novartis AG, Perrigo Co. Plc, and Takeda Pharmaceutical Co. Ltd. Also, the tobacco alternative gums market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Type
Market Segmentation by Distribution Channel
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global tobacco alternative gums market: Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, ITC Ltd., Johnson & Johnson, Novartis AG, Perrigo Co. Plc, and Takeda Pharmaceutical Co. Ltd.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising prices of cigarettes."
According to the report, one of the major drivers for this market is the demand for nicotine gum in smoking cessation therapy.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alchem International Pvt. Ltd.
- Cambrex Corp.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- GlaxoSmithKline Plc
- ITC Ltd.
- Johnson & Johnson
- Novartis AG
- Perrigo Co. Plc
- Takeda Pharmaceutical Co. Ltd.
